STOCK TITAN

Smead Capital (MAC) reports 12.16M shares, holding 4.74% in Macerich

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Smead Capital Management filed an amendment reporting beneficial ownership of 12,155,332.57 shares of Macerich Company common stock, representing 4.74% of the class. The filing is a joint Schedule 13G/A amendment signed by Smead Capital, William W. Smead, and Cole W. Smead.

The report lists sole voting and dispositive power over 12,155,332.57 shares and provides the issuer's principal office address in Santa Monica, California.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake reported: Smead holds 4.74% of Macerich.

The amendment records 12,155,332.57 shares beneficially owned with sole voting and dispositive power. As a Schedule 13G/A filing, this typically indicates an investment manager reporting a passive position rather than an active acquisition intent.

Materiality depends on context: the 4.74% stake is below the 5% threshold that often triggers different disclosure regimes. Subsequent filings could change the picture if ownership crosses regulatory thresholds.

Filing appears procedurally complete and joint.

The form includes a joint filing statement under Rule 13d-1(k) and signatures from the CI0, CEO, and Chief Compliance Officer. It lists CUSIP 554382101 and the issuer address verbatim.

Investors seeking changes in control or voting coordination should watch for any future amendments that alter percent ownership or disclose coordinated activity.

Beneficial ownership 12,155,332.57 shares reported on Schedule 13G/A
Percent of class 4.74% percent of common stock class
CUSIP 554382101 Macerich Company common stock identifier
Filing date (signature) April 22, 2026 date of joint filing signatures
Schedule 13G/A regulatory
"Amendment No. 4 SCHEDULE 13G/A"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 12,155,332.57"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
joint filing statement regulatory
"JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)"





554382101

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Smead Capital Management, Inc.
Signature:Brian Briggs
Name/Title:Brian Briggs | Chief Compliance Officer
Date:04/22/2026
William W. Smead
Signature:William W. Smead
Name/Title:William W. Smead | Chief Investment Officer
Date:04/22/2026
Cole W. Smead
Signature:Cole W. Smead
Name/Title:Cole W. Smead | President & Chief Executive Officer
Date:04/22/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G/A, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: April 22, 2026 Smead Capital Management, Inc. /s/ Brian Briggs Brian Briggs | Chief Compliance Officer William W. Smead /s/ William W. Smead | Chief Investment Officer Cole W. Smead /s/ Cole W. Smead | President & Chief Executive Officer

FAQ

What stake does Smead Capital report in Macerich (MAC)?

Smead Capital reports beneficial ownership of 12,155,332.57 shares, or 4.74% of the class. The Schedule 13G/A amendment lists sole voting and dispositive power over the full share count and identifies CUSIP 554382101.

Does the filing indicate Smead controls voting for the shares?

Yes. The amendment states sole voting power and sole dispositive power over 12,155,332.57 shares. That language shows Smead reports the ability to vote and dispose of the shares it beneficially owns.

Is this a joint filing and who signed it?

Yes. It is a joint filing under Rule 13d-1(k). Signatories include Brian Briggs (Chief Compliance Officer), William W. Smead (Chief Investment Officer), and Cole W. Smead (President & CEO), dated April 22, 2026.

Does the filing imply activist intentions by Smead Capital?

The Schedule 13G/A form typically signals a passive investor position rather than an activist campaign. The amendment does not disclose coordinated or activist intentions; it records ownership and joint filing status only.

What issuer details are included in the amendment?

The issuer is Macerich Company with CUSIP 554382101. The principal executive office is listed as 410 Wilshire Blvd Suite 700, Santa Monica, CA 90401 in the amendment.